NanoViricides
NNVC
27 hedge funds and large institutions have $2.45M invested in NanoViricides in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.
1,750% more call options, than puts
Call options by funds: $74K | Put options by funds: $4K
0.51% more ownership
Funds ownership: 9.62% → 10.14% (+0.51%)
7% less funds holding
Funds holding: 29 → 27 (-2)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
41% less capital invested
Capital invested by funds: $4.13M → $2.45M (-$1.68M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$187K |
| 2 |
Renaissance Technologies
New York
|
+$75.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$21.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.22K |
| 5 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$1.05K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$108K |
| 2 |
HIS
Harvest Investment Services
Oakbrook Terrace,
Illinois
|
-$53K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$31.8K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$14.7K |
| 5 |
BlackRock
New York
|
-$3.26K |
NNVC Hedge Fund Activity: Q1 2022 in Review
27 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q1 2022, worth a combined $2.45M — down 41% from $4.13M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of NNVC and 3 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 4 added.
The largest buyer was Compagnie Lombard Odier SCmA, adding an estimated $187K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $108K sold.
- 27 institutional investors held NanoViricides (NNVC) as of Q1 2022, down from 29 in Q4 2021.
- Funds reported $2.45M of NanoViricides stock for Q1 2022, down 41% quarter-over-quarter.
- 3 funds opened new NanoViricides positions in Q1 2022 and 5 closed out, a net change of -2 holders.
- The largest NanoViricides buyer in Q1 2022 was Compagnie Lombard Odier SCmA, an estimated $187K added.
- The largest NanoViricides seller in Q1 2022 was Dimensional Fund Advisors, an estimated $108K sold.
Based on aggregated 13F filings for Q1 2022.